Stay updated with breaking news from Japan Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stocks in London are called to follow New York higher on Friday morning, after the Bank of England left interest rates on hold in a split decision. At its February meeting, the BoE kept its bank rate...
AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan. The Cambridge,...
- Phase 3 open-label, single-arm study conducted in Japan by BridgeBio licensing partner Alexion, AstraZeneca Rare Disease showed consistency with global ATTRibute-CM Phase III trial - No mortality...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.